Wednesday, November 15, 2023 11:17:15 AM
https://www.investopedia.com/ask/answers/011315/what-difference-between-authorized-shares-and-outstanding-shares.asp#
Authorized shares are the maximum number of shares a company is allowed to issue to investors as laid out in its articles of incorporation.
Outstanding shares are the actual shares issued or sold to investors from the available number of authorized shares.
Authorized shares are the maximum number of shares a company is allowed to issue to investors as laid out in its articles of incorporation.
Outstanding shares are the actual shares issued or sold to investors from the available number of authorized shares.
Recent SNWV News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/02/2026 09:10:02 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/02/2026 09:09:13 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/02/2026 09:08:30 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/02/2026 09:07:47 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/02/2026 09:06:51 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/26/2026 09:04:08 PM
- Sanuwave Announces Record Revenues and Financial Results for Q4 and Full Year 2025 • GlobeNewswire Inc. • 03/26/2026 09:00:00 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/26/2026 08:31:26 PM
- Sanuwave Will Host a Conference Call on March 27, 2026 at 8:30 AM (ET) to Present Q4 and Full Year 2025 Financial Results • GlobeNewswire Inc. • 03/20/2026 05:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/13/2026 08:33:30 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/03/2026 09:04:10 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/03/2026 09:02:11 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 01/15/2026 09:33:05 PM
- Sanuwave Health Announces Preliminary Q4 2025 Revenue of $13.3–$13.4 Million, Up 29–30% Year-over-Year; Achieves Record Quarterly and Full-Year Revenue • GlobeNewswire Inc. • 01/09/2026 10:00:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/06/2026 09:37:08 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/06/2026 09:35:33 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/06/2026 09:34:54 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/06/2026 09:34:14 PM
- Sanuwave to Participate in the 44th Annual J.P. Morgan Healthcare Conference • GlobeNewswire Inc. • 12/10/2025 11:00:00 AM
- Sanuwave Announces the Addition of UltraMIST to Healogics Group Purchasing Organization (GPO), iSupply • GlobeNewswire Inc. • 12/08/2025 11:00:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/07/2025 11:10:06 AM
- Sanuwave Announces Q3 FY2025 Financial Results • GlobeNewswire Inc. • 11/07/2025 11:00:00 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/06/2025 09:52:01 PM
- Sanuwave Will Host a Conference Call on November 7, 2025 at 8:30 AM (ET) to Present Q3 2025 Financial Results • GlobeNewswire Inc. • 11/03/2025 09:35:00 PM
